ArticlePharmacoEconomics2013

A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillation.

Sonja V Sorensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.